All News

gcascalp_0.jpg

How Age of Onset Affects Giant Cell Arteritis

d MedPage Today

Giant cell arteritis (GCA) has a different phenotype when diagnosed late in life compared with earlier onset, a large Italian cohort study indicated.

Read Article
DXA1.jpg (keep)

FRAX Tool is Suboptimal in Predicting Osteoporosis Fracture Risk in Younger Post-menopausal Women

d EurekAlert!

The commonly used Fracture Risk Assessment Tool (FRAX), which includes self-identified race and ethnicity information, and the Osteoporosis Self-Assessment Tool (OST), which does not, had suboptimal performance in determining major osteoporotic fracture risk across racial/ethnic categories in you

Read Article
acupuncture.jpg

The Burden of Chronic Pain in US Adults (2019-2020)

d Jack Cush, MD

Analysis of National Health Interview Survey data shows that the incidence of chronic pain in the USA is high compared with other chronic diseases.

Read Article
ANCA, vasculitis, test

International Consensus on ANCA-Associated Vasculitis with Glomerulonephritis

d Jack Cush, MD

Nephrology Dialysis Transplantation has published an overview of the management of anti-neutrophil cytoplasmic antibody associated vasculitis with glomerulonephritis based on several international guidelines, including those frorm the ACR 2021, EULAR 2022 and KDIGO 2021 (Kidney Disease: Improving

Read Article
Colchicine does not work in Hand OA. Danish trial of 100 HOA pts (age 71 yrs) given placebo or COL 0.5 mg bid x 12wk. Finger pain improved –13·9 mm w/ colchicine vs –13·5 mm w/ PBO (NS). More adverse events w/ Colchicine (72% vs 44%) https://t.co/rfANCLcZii https://t.co/OFuMGZSvhm

Links:

Dr. John Cush RheumNow ( View Tweet)
Risk factors for radiographic progression: Men ♂️ Smoking 🚬 Active inflammation🔥 Blue collar workers 💪 HLA-B27+ 💉 Pre-existing syndesmophyte 🩻 Atul Deodhar at #RNL2023 @RheumNow https://t.co/FcwrDtOG6I https://t.co/AvRpPrg1UK

Links:

Dr. John Cush RheumNow ( View Tweet)
BIOBADASER registry of 3,366 RA/AS/PsA pts on 1,2 bDMARDs saw Remission-related Biologic D/C by 80 pts (2.4%). D/C Factors: short Dz duration (OR: 0.95), no csDMARDs (OR:0.56), shorter use prior bDMARD. Less D/C w/ smoking & ACPA+ https://t.co/iUdU9iI4AZ https://t.co/TknRW6pnJR

Links:

Dr. John Cush RheumNow ( View Tweet)
INBUILD study was an all cause ILD nintedanib RCT (n=663). Subanalysis of 89 RA-ILD pts showed FVC decline (@ 52 wks) was −82.6 mL/yr on NIN vs −199.3 mL/yr on PBO (p=.037). NIN diarrhea in 62%; & AE discontinuation in 24% https://t.co/nWuGx6wjB2 https://t.co/LVwy1Z5TL3

Links:

Dr. John Cush RheumNow ( View Tweet)
Tuesday Night Rheumatology: POD 7: Spondyloarthritis Innovations https://t.co/eDZlgdeWGr

Links:

Dr. John Cush RheumNow ( View Tweet)

Dr. Atul Deodhar on AxSpA - 5-40% of nr-axSpA progress to r-axSpA over 2-10 years - is non-radiographic axSpA a misnomer? @RheumNow #RNL2023 https://t.co/HaavCnplO0 https://t.co/3jQaxVfFBH

Links:

Dr. John Cush RheumNow ( View Tweet)
Dr. Deodhar reminds us of his "3,4,5 rule" for diagnosing AS. *Erosions in 3 or more SIJ quadrants *BME in 4 or more SIJ quadrants *Fat lesions in 5 of more SIJ quadrants #RNL2023 @RheumNow https://t.co/6iAXKfZvEY https://t.co/kxqbiXVd2w

Links:

Dr. John Cush RheumNow ( View Tweet)
#RNL2023 @RheumNow Atul Deodhar: Prevalence of AS is increasing! Is it truly more? Or likely better recognized and diagnosed, as well as increased recognition of nr-AxSpa https://t.co/HnzRrKko75 https://t.co/CBbvFIbRoi

Links:

Dr. John Cush RheumNow ( View Tweet)
Allergic Drug-Induced Arthritis Dr. Jack Cush reviews the news and journal reports from this past week on https://t.co/iRqfkFu52z. This week we delve into some odd associations, repeat drug warnings and the consequences of antirheumatic therapies. https://t.co/lRBaXMAgz6 https://t.co/37gIHniIEi

Links:

Dr. John Cush RheumNow ( View Tweet)
Microbiome of Hip and Knee Osteoarthritis is not "Sterile" NGS techniques show the presence of bacterial DNA in surgical specimens of hip and knee arthritis, from patients undergoing first-time total joint arthroplasty, reports a study. https://t.co/FIUG73x21N https://t.co/kNHgKiuxHM

Links:

Dr. John Cush RheumNow ( View Tweet)
Peresolimab's Potential in Rheumatoid Arthritis Peresolimab is a humanized IgG1 monoclonal antibody that acts as a PD-1 agonist (stimulator). The NEJM reports that PER met its efficacy primary endpont in treating patients with active RA. https://t.co/B3tApMEWI3 https://t.co/Qi3WQkwvRd

Links:

Dr. John Cush RheumNow ( View Tweet)
Medevil ruler Bermudo II ("The Gouty", in Spanish: "el Gotoso") was King of León & Galicia (982 to 999). Some campaigns were a success but he lost wars & reign, presumeably from severe gout & could no longer ride horseback, & had to travel by litter https://t.co/xxzRNUY2mv https://t.co/YQRwGixd4Y

Links:

Dr. John Cush RheumNow ( View Tweet)
14 yr study #SLE (255 pts) & Lymphadenopathy. Causes: SLE (33.7%), lymphoma (0.8%) or TB (0.4%). LAD assoc w/ with fever (OR=3.3), pericarditis (4.1), membranous GN (3.6), leukopenia (2.6); NOT Wt loss, myocarditis, myositis. Bx needed to R/O lymphoma. https://t.co/WzCmtOVQWm https://t.co/rMEujVv9e2

Links:

Dr. John Cush RheumNow ( View Tweet)
82 Patients with Knee OA and Severe Obesity, showed that Bariatric Surgery and Weight Loss Before TKA significantly Reduced Complications Versus TKA Alone (without Wt loss surgery). TKA was delayed 17 (vs 4 mos) in Wt loss group.https://t.co/JR3BUqthhy https://t.co/q93AI4cpK0

Links:

Dr. John Cush RheumNow ( View Tweet)
In 2020, there were 619 million back pain cases Worldwide; this is expected to grown by 50% to 843 million people by 2050, due to ageing of populations. https://t.co/ruB0gfMoFm https://t.co/UATKXRVj9p

Links:

Dr. John Cush RheumNow ( View Tweet)
82 Patients with Knee OA and Severe Obesity, showed that Bariatric Surgery and Weight Loss Before TKA significantly Reduced Complications Versus TKA Alone (without Wt loss surgery). TKA was delayed 17 (vs 4 mos) in Wt loss group.https://t.co/JR3BUqthhy https://t.co/mUh5FfSUBR

Links:

Dr. John Cush RheumNow ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×